AMRX Stock Ownership Breakdown

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own AMRX shares is 260, representing 46.46% of the company's common stock.

SUSQUEHANNA INTERNATIONAL GROUP, LLP, in the last quarter, reduced its stake in AMRX by -7.14% restricting it's holding to 666.75 thousand shares of worth nearly $4.04M. PHOCAS FINANCIAL CORP. also lessened -2.49% of the AMRX shares from its portfolio, reducing its holding to 697.08 thousand shares of worth $4.22M. FOSUN INTERNATIONAL LTD also shunned AMRX shares holding by -42.78% last quarter which brought its holding to 12.31 million shares worth $74.62M.

As per its latest 13F filing, RENAISSANCE TECHNOLOGIES LLC increased its stake in AMRX by 156.37% in the last quarter. The institutional holder raised its holding to 532.73 thousand shares having worth more than $3.23M. CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. also added 11.85% more shares of AMRX to its portfolio, raising its holding to 533.43 thousand shares of worth $3.23M. WOODLINE PARTNERS LP also increased its AMRX shares holding by 100% which brought its holding to 688.11 thousand shares worth $4.17M.

The insider with the most stakes in AMRX is TPG GP A, LLC , director at the company. Additionally, AMRX stock is highly held by director Patel Gautam and director MEISTER PAUL M among others.

Company executives, directors, and other insiders own 52.16% percent of Amneal Pharmaceuticals, Inc.'s stock. Within the last six months, there have been 10 transaction(s) in which AMRX insiders have sold stock, totaling 357.09K shares. Insiders that have sold shares include PATEL GAUTAM, AUTOR DEBORAH M., and KIELY JOHN.

There have been 0 transaction(s) during the past 6-months in which Amneal Pharmaceuticals, Inc. insiders have bought stock, totalling 0 shares

Around 5.27M Amneal Pharmaceuticals, Inc. shares are held by insiders, which represents about 52.16% of AMRX stock.

AMRX director, TPG GP A, LLC holds the largest portfolio of the company's shares. AMRX shares owned by TPG total nearly 12.33 million.

RENAISSANCE TECHNOLOGIES LLC is the largest institutional owner in AMRX which holds 532.73 thousand shares worth $3.23M or 0.3% of the total AMRX shares outstanding followed by CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. with ownership of 533.43 thousand shares representing 0.3% of the AMRX ownership. SUSQUEHANNA INTERNATIONAL GROUP, LLP is the third largest stakeholder with 666.75 thousand shares or 0.38% of the ownership worth more than $4.04M.

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the AMRX is concerned, it is a stock which is optionable.

Number of AMRX shares short is 3.30M. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

As of today, 309.84M shares of AMRX are outstanding.

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, AMRX has 141.52M shares in float.

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for AMRX is 2.88.